The New York Times reports:
The antibody cocktail for Covid-19 that President Trump touted on Wednesday afternoon was developed with cells originally derived from fetal tissue, a practice that the president had repeatedly condemned. In June 2019, the Trump administration suspended federal funding for most new scientific research involving fetal tissue derived from abortions.
“Promoting the dignity of human life from conception to natural death is one of the very top priorities of President Trump’s administration,” the Department of Health and Human Services said in a prepared statement. “Intramural research that requires new acquisition of fetal tissue from elective abortions will not be conducted,” the statement added.
The treatment Trump promoted yesterday as a “cure” for coronavirus was developed with cells derived from fetal tissue, a practice he has repeatedly condemned.
I won’t hold my breath waiting for the hypocritical “pro-life” conservatives to condemn him. https://t.co/ep7dyaozXO
— Keith Boykin (@keithboykin) October 8, 2020
“Trump’s antibody treatment was tested using cells originally derived from an #abortion.
The #Trump administration has looked to curtail research with fetal cells. But when it was life or death for the president, no one objected.”#COVID19https://t.co/8Uf8lzivBb
— Laurie Garrett (@Laurie_Garrett) October 8, 2020
Regeneron’s monoclonal antibody cocktail that Trump credits for “curing” him from COVID-19 wouldn’t even exist without the human embryonic stem cell and fetal tissue research that Marsha Blackburn sent two armed US Marshals to subpoena me to Congress to stop me from doing. Irony.
— Eugene Gu, MD (@eugenegu) October 7, 2020
The president was treated with antibodies developed using fetal tissue. Should opponents of abortion object? https://t.co/OIgcuxB8yd
— Ramesh Ponnuru (@RameshPonnuru) October 8, 2020